Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study

Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study

Abstract Background This study examines the association of standard-of-care systemic lupus erythematosus (SLE) medications with key outcomes such as low disease activity attainment, flares, damage accrual, and steroid-sparing, for which there is current paucity of data. Methods The Asia Pacific Lupu...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Ricardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, Shereen Oon, Alicia Calderone, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian Jan Wu, Vera Golder, Aisha Lateef, Sandra V. Navarra, Leonid Zamora, Laniyati Hamijoyo, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Fiona Goldblatt, Sean O’Neill, Chak Sing Lau, Jiacai Cho, Alberta Hoi, Chetan S. Karyekar, Eric F. Morand, Mandana Nikpour
Format: Artykuł
Język:English
Wydane: BMC 2024-05-01
Seria:Advances in Rheumatology
Hasła przedmiotowe:
Anti-malarials
Autoimmune diseases
Cohort study
Immunosuppressants
Systemic lupus erythematosus
SLEDAI
Dostęp online:https://doi.org/10.1186/s42358-024-00366-y

Internet

https://doi.org/10.1186/s42358-024-00366-y

Podobne zapisy